Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$65,562,688
-$1,777,880 QoQ
Shares Held
912,367
+60.2% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#77
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,562,688 | 912,367 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $67,340,568 | 569,669 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $19,438,682 | 154,496 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $48,689,438 | 332,760 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $21,249,118 | 136,256 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $30,166,673 | 183,217 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $40,757,263 | 250,152 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $45,885,771 | 234,854 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $40,899,262 | 235,921 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $47,000,611 | 277,765 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $31,873,081 | 161,489 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $25,793,054 | 148,253 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $21,553,972 | 125,161 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $19,553,036 | 117,478 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $16,775,868 | 114,472 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $17,405,239 | 117,373 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $57,165,627 | 332,571 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $209,104,252 | 1,108,777 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $248,712,200 | 1,019,187 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $135,808,694 | 699,540 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $128,674,867 | 690,464 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $105,106,715 | 667,429 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $115,860,094 | 700,061 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $110,841,390 | 670,263 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $69,771,995 | 509,136 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $43,012,868 | 365,476 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||